151 related articles for article (PubMed ID: 25379695)
1. p-Synephrine suppresses glucose production but not lipid accumulation in H4IIE liver cells.
Cui Z; Lee Y; Lee Y; Park D
J Med Food; 2015 Jan; 18(1):76-82. PubMed ID: 25379695
[TBL] [Abstract][Full Text] [Related]
2. p-Synephrine stimulates glucose consumption via AMPK in L6 skeletal muscle cells.
Hong NY; Cui ZG; Kang HK; Lee DH; Lee YK; Park DB
Biochem Biophys Res Commun; 2012 Feb; 418(4):720-4. PubMed ID: 22306011
[TBL] [Abstract][Full Text] [Related]
3. Effects of Citrus aurantium (bitter orange) fruit extracts and p-synephrine on metabolic fluxes in the rat liver.
Peixoto JS; Comar JF; Moreira CT; Soares AA; de Oliveira AL; Bracht A; Peralta RM
Molecules; 2012 May; 17(5):5854-69. PubMed ID: 22592089
[TBL] [Abstract][Full Text] [Related]
4. The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine.
Stohs SJ; Preuss HG; Shara M
Phytother Res; 2011 Oct; 25(10):1421-8. PubMed ID: 21480414
[TBL] [Abstract][Full Text] [Related]
5. The action of p-synephrine on hepatic carbohydrate metabolism and respiration occurs via both Ca(2+)-mobilization and cAMP production.
de Oliveira AL; Comar JF; de Sá-Nakanishi AB; Peralta RM; Bracht A
Mol Cell Biochem; 2014 Mar; 388(1-2):135-47. PubMed ID: 24287564
[TBL] [Abstract][Full Text] [Related]
6. Isopropylnorsynephrine is a stronger lipolytic agent in human adipocytes than synephrine and other amines present in Citrus aurantium.
Mercader J; Wanecq E; Chen J; Carpéné C
J Physiol Biochem; 2011 Sep; 67(3):443-52. PubMed ID: 21336650
[TBL] [Abstract][Full Text] [Related]
7. Safety, Efficacy, and Mechanistic Studies Regarding Citrus aurantium (Bitter Orange) Extract and p-Synephrine.
Stohs SJ
Phytother Res; 2017 Oct; 31(10):1463-1474. PubMed ID: 28752649
[TBL] [Abstract][Full Text] [Related]
8. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine.
Stohs SJ; Preuss HG; Shara M
Int J Med Sci; 2012; 9(7):527-38. PubMed ID: 22991491
[TBL] [Abstract][Full Text] [Related]
9. Unmetabolized fenofibrate, but not fenofibric acid, activates AMPK and inhibits the expression of phosphoenolpyruvate carboxykinase in hepatocytes.
Murakami R; Murakami H; Kataoka H; Cheng XW; Takahashi R; Numaguchi Y; Murohara T; Okumura K
Life Sci; 2010 Oct; 87(15-16):495-500. PubMed ID: 20849861
[TBL] [Abstract][Full Text] [Related]
10. Actions of p-synephrine on hepatic enzyme activities linked to carbohydrate metabolism and ATP levels in vivo and in the perfused rat liver.
Maldonado MR; Bracht L; de Sá-Nakanishi AB; Corrêa RCG; Comar JF; Peralta RM; Bracht A
Cell Biochem Funct; 2018 Jan; 36(1):4-12. PubMed ID: 29270996
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Safety of Oral p-Synephrine (Bitter Orange) in Healthy Subjects: A Randomized Placebo-Controlled Cross-over Clinical Trial.
Shara M; Stohs SJ; Mukattash TL
Phytother Res; 2016 May; 30(5):842-7. PubMed ID: 26948284
[TBL] [Abstract][Full Text] [Related]
12. A 60day double-blind, placebo-controlled safety study involving Citrus aurantium (bitter orange) extract.
Kaats GR; Miller H; Preuss HG; Stohs SJ
Food Chem Toxicol; 2013 May; 55():358-62. PubMed ID: 23354394
[TBL] [Abstract][Full Text] [Related]
13. Citrus junos Tanaka peel ameliorates hepatic lipid accumulation in HepG2 cells and in mice fed a high-cholesterol diet.
Shin EJ; Park JH; Sung MJ; Chung MY; Hwang JT
BMC Complement Altern Med; 2016 Dec; 16(1):499. PubMed ID: 27912736
[TBL] [Abstract][Full Text] [Related]
14. Safety evaluation of p-synephrine following 15 days of oral administration to healthy subjects: A clinical study.
Shara M; Stohs SJ; Smadi MM
Phytother Res; 2018 Jan; 32(1):125-131. PubMed ID: 29130542
[TBL] [Abstract][Full Text] [Related]
15. [Synephrine in dietary supplements and specialized foodstuffs: biological activity, safety and methods of analysis].
Perova IB; Eller KI; Musatov AV; Tymolskaya EV
Vopr Pitan; 2021; 90(6):101-113. PubMed ID: 35032130
[TBL] [Abstract][Full Text] [Related]
16. Physiological effects following administration of Citrus aurantium for 28 days in rats.
Hansen DK; George NI; White GE; Pellicore LS; Abdel-Rahman A; Fabricant D;
Toxicol Appl Pharmacol; 2012 Jun; 261(3):236-47. PubMed ID: 22521485
[TBL] [Abstract][Full Text] [Related]
17. Fast hepatic biotransformation of p-synephrine and p-octopamine and implications for their oral intake.
da Silva-Pereira JF; Bubna GA; Gonçalves Gde A; Bracht F; Peralta RM; Bracht A
Food Funct; 2016 Mar; 7(3):1483-91. PubMed ID: 26883936
[TBL] [Abstract][Full Text] [Related]
18. A review of the receptor-binding properties of p-synephrine as related to its pharmacological effects.
Stohs SJ; Preuss HG; Shara M
Oxid Med Cell Longev; 2011; 2011():482973. PubMed ID: 21904645
[TBL] [Abstract][Full Text] [Related]
19. Co-Existence of Hypertensive and Anti-Hypertensive Constituents, Synephrine, and Nobiletin in
Kim JJ; Kim K; Jung YR; Bian Y; Ngo T; Bae ON; Lim KM; Chung JH
Molecules; 2019 Mar; 24(7):. PubMed ID: 30934724
[TBL] [Abstract][Full Text] [Related]
20. An active part of Artemisia sacrorum Ledeb. suppresses gluconeogenesis through AMPK mediated GSK3β and CREB phosphorylation in human HepG2 cells.
Yuan HD; Piao GC
Biosci Biotechnol Biochem; 2011; 75(6):1079-84. PubMed ID: 21670525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
